196 related articles for article (PubMed ID: 34471711)
1. Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt.
Fateen E; Abdallah ZY; Nazim WS; Ibrahim M; Radwan A
Heliyon; 2021 Aug; 7(8):e07830. PubMed ID: 34471711
[TBL] [Abstract][Full Text] [Related]
2. Separation of sulfated urinary glycosaminoglycans by high-resolution electrophoresis for isotyping of mucopolysaccharidoses in Malaysia.
Nor A; Zabedah MY; Norsiah MD; Ngu LH; Suhaila AR
Malays J Pathol; 2010 Jun; 32(1):35-42. PubMed ID: 20614724
[TBL] [Abstract][Full Text] [Related]
3. Disease burden, management patterns and multidisciplinary clinical approaches for patients with MPS IVA and VI in selected Latin American Countries.
Solano VM; Mandujano CYC; Avila-Rejon CA; Espin VH; Montaño HPQ
Mol Genet Metab Rep; 2021 Sep; 28():100769. PubMed ID: 34113545
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans.
Arunkumar N; Vu DC; Khan S; Kobayashi H; Ngoc Can TB; Oguni T; Watanabe J; Tanaka M; Yamaguchi S; Taketani T; Ago Y; Ohnishi H; Saikia S; Álvarez JV; Tomatsu S
Diagnostics (Basel); 2021 Jul; 11(8):. PubMed ID: 34441282
[TBL] [Abstract][Full Text] [Related]
5. [Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].
Giugliani R; Federhen A; Muñoz Rojas MV; Vieira TA; Artigalás O; Pinto LL; Azevedo AC; Acosta AX; Bomfim C; Lourenço CM; Kim CA; Horovitz D; Souza DB; Norato D; Marinho D; Palhares D; Santos ES; Ribeiro E; Valadares ER; Guarany F; De Lucca GR; Pimentel H; Souza IN; Corrêa Neto J; Fraga JC; Góes JE; Cabral JM; Simeonato J; Llerena JC; Jardim LB; Giuliani Lde R; Silva LC; Santos M; Moreira MA; Kerstenetzky M; Ribeiro M; Ruas N; Barrios P; Aranda P; Honjo R; Boy R; Costa R; Souza CF; Alcântara FF; Avilla SG; Fagondes S; Martins AM
Rev Assoc Med Bras (1992); 2010; 56(3):271-7. PubMed ID: 20676532
[TBL] [Abstract][Full Text] [Related]
6. Oxidative profile exhibited by Mucopolysaccharidosis type IVA patients at diagnosis: Increased keratan urinary levels.
Donida B; Marchetti DP; Jacques CED; Ribas G; Deon M; Manini P; da Rosa HT; Moura DJ; Saffi J; Giugliani R; Vargas CR
Mol Genet Metab Rep; 2017 Jun; 11():46-53. PubMed ID: 28487826
[TBL] [Abstract][Full Text] [Related]
7. Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses.
Kakkis E; Marsden D
Mol Genet Metab; 2020 May; 130(1):7-15. PubMed ID: 32224020
[TBL] [Abstract][Full Text] [Related]
8. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan.
Chuang CK; Lin HY; Wang TJ; Huang YH; Chan MJ; Liao HC; Lo YT; Wang LY; Tu RY; Fang YY; Chen TL; Ho HC; Chiang CC; Lin SP
Orphanet J Rare Dis; 2018 May; 13(1):84. PubMed ID: 29801497
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of mucopolysaccharidoses (MPS): the first Egyptian experience.
Aboul Nasr A; Fateen E
Bratisl Lek Listy; 2004; 105(9):310-4. PubMed ID: 15633892
[TBL] [Abstract][Full Text] [Related]
10. The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centers.
Tylki-Szymańska A; Almássy Z; Christophidou-Anastasiadou V; Avdjieva-Tzavella D; Barisic I; Cerkauskiene R; Cuturilo G; Djiordjevic M; Gucev Z; Hlavata A; Kieć-Wilk B; Magner M; Pecin I; Plaiasu V; Samardzic M; Zafeiriou D; Zaganas I; Lampe C
Orphanet J Rare Dis; 2022 Mar; 17(1):136. PubMed ID: 35331284
[TBL] [Abstract][Full Text] [Related]
11. A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management.
Zhou J; Lin J; Leung WT; Wang L
Intractable Rare Dis Res; 2020 Feb; 9(1):1-9. PubMed ID: 32201668
[TBL] [Abstract][Full Text] [Related]
12. Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study.
Sestito S; Rinninella G; Rampazzo A; D'Avanzo F; Zampini L; Santoro L; Gabrielli O; Fiumara A; Barone R; Volpi N; Scarpa M; Tomanin R; Concolino D
Orphanet J Rare Dis; 2022 Jun; 17(1):251. PubMed ID: 35768874
[TBL] [Abstract][Full Text] [Related]
13. The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: A longitudinal analysis.
Kenth JJ; Thompson G; Fullwood C; Wilkinson S; Jones S; Bruce IA
Mol Genet Metab Rep; 2019 Sep; 20():100487. PubMed ID: 31341787
[TBL] [Abstract][Full Text] [Related]
14. Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots.
Ullal AJ; Millington DS; Bali DS
Mol Genet Metab Rep; 2014; 1():461-464. PubMed ID: 27896123
[TBL] [Abstract][Full Text] [Related]
15. Selective screening for detection of mucopolysaccharidoses in Malaysia; A two-year study (2014-2016).
Omar A; Jalil JA; Shakrin NM; Ngu LH; Yunus ZM
Mol Genet Metab Rep; 2019 Jun; 19():100469. PubMed ID: 31193155
[TBL] [Abstract][Full Text] [Related]
16. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
Tomatsu S; Sawamoto K; Alméciga-Díaz CJ; Shimada T; Bober MB; Chinen Y; Yabe H; Montaño AM; Giugliani R; Kubaski F; Yasuda E; Rodríguez-López A; Espejo-Mojica AJ; Sánchez OF; Mason RW; Barrera LA; Mackenzie WG; Orii T
Drug Des Devel Ther; 2015; 9():1937-53. PubMed ID: 25897204
[TBL] [Abstract][Full Text] [Related]
17. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
[TBL] [Abstract][Full Text] [Related]
18. [Enzymatic diagnosis and clinical characteristics of 52 children with mucopolysaccharidosis].
Huang YL; Li SY; Zhao XY; Fan LP; Lin WC; Zhou ZH; Cheng J; Liu L
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jul; 14(7):510-4. PubMed ID: 22809603
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA.
Lee SH; Kim HY; Cho TJ; Kim H; Ko JM
Mol Genet Metab Rep; 2022 Jun; 31():100869. PubMed ID: 35782601
[TBL] [Abstract][Full Text] [Related]
20. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
